The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Open accessPreprint — published as 10.1164/rccm.202001-0179le · Paper page
Abstract
Abstract A novel coronavirus SARS-CoV-2 was identified in Wuhan, Hubei Province, China in December of 2019. According to WHO report, this new coronavirus has resulted in 76,392 confirmed infections and 2,348 deaths in China by 22 February, 2020, with additional patients being identified in a rapidly growing number internationally. SARS-CoV-2 was reported to share the same receptor, Angiotensin-converting enzyme 2 (ACE2), with SARS-CoV. Here based on the public database and the state-of-the-art single-cell RNA-Seq technique, we analyzed the ACE2 RNA expression profile in the normal human lungs. The result indicates that the ACE2 virus receptor expression is concentrated in a small population of type II alveolar cells (AT2). Surprisingly, we found that this population of ACE2-expressing AT2 also highly expressed many other genes that positively regulating viral entry, reproduction and transmission. This study provides a biological background for the epidemic investigation of the COVID-19, and could be informative for future anti-ACE2 therapeutic strategy development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SARS-CoV-2 mainly infect alveolar epithelial type II (AE2) cells (Zhao et al., 2020)”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Zhao et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,202
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,117
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion ConformationPreprint
Wrapp, D., Wang, N., Corbett, K. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.11.944462 · Cited by 1,010
Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2951-z · Cited by 715
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- 2020, Novel Wuhan (2019-nCoV) Coronavirus, American Journal of Respiratory and Critical Care Medicine, 201, P7
- Zhao Y , Zhao ZX , Wang YJ , Zhou YQ , Ma Y , Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv 2020.01.26.919985.
Cited by
Sorted by citations
Items 201–300 of 850
Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
Depfenhart, M., de Villiers, D., Lemperle, G. H., Meyer, M., & Somma, S. D. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02383-3 · Cited by 83
O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares
Aşkın, L., Tanrıverdi, O., & Aşkın, H. Ş. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200273 · Cited by 91
Severe COVID-19: what have we learned with the immunopathogenesis?
Corrêa, B. B., Rodrigues, M. B., Cortez, A. F., Vieira, M., & Pinheiro, M. M. (2020) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-020-00151-7 · Cited by 83
Lin, W., Fan, J., Hu, L., Zhang, Y., Ooi, J. D., Meng, T., Jin, P., Ding, X., Peng, L., Song, L., et al. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001439 · Cited by 77
Endothelial cells and SARS-CoV-2: An intimate relationship
Barbosa, L. C., Gonçalves, T. L., de Araújo, L. P., Rosário, L., & Ferrer, V. P. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106829 · Cited by 78
Ictus como complicación y como factor pronóstico de COVID-19
Trejo-Gabriel-Galan, J. M. (2020) · Neurología · doi:10.1016/j.nrl.2020.04.015 · Cited by 80
Awadasseid, A., Wu, Y., Tanaka, Y., & Zhang, W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45018 · Cited by 76
COVID-19: etiology, clinical picture, treatment
MIu, S., Колобухина, Л. В., Burgasova, O., Сергеевна, К. И., & Vv, M. (2020) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-cec-1473 · Cited by 73
Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
Gemmati, D., & Tisato, V. (2020) · Genes · doi:10.3390/genes11091044 · Cited by 75
Tripathy, S., Verma, D. K., Thakur, M., Patel, A. R., Srivastav, P. P., Sıngh, S., Gupta, A. K., Chávez‐González, M. L., Aguilar, C. N., Chakravorty, N., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.747956 · Cited by 81
Inde, Z., Croker, B. A., Yapp, C., Joshi, G. N., Spetz, J. K. E., Fraser, C. S., Qin, X., Xu, L., Deskin, B., Ghelfi, E., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf8609 · Cited by 72
Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
Cheng, P. P., Zhu, H., Witteles, R. M., Wu, J. C., Quertermous, T., Wu, S. M., & Rhee, J. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01293-2 · Cited by 71
Aktaş, G. (2020) · Experimental Biomedical Research · doi:10.30714/j-ebr.2020463629 · Cited by 72
Guo, J., Wei, X., Li, Q., Li, L., Yang, Z., Shi, Y., Qin, Y., Zhang, X., Wang, X., Zhi, X., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29802 · Cited by 70
Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients
Wang, H., Tang, X., Fan, H., Luo, Y., Song, Y., Xu, Y., & Chen, Y. (2020) · Aging · doi:10.18632/aging.103335 · Cited by 69
Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
Allegretti, M., Cesta, M. C., Zippoli, M., Beccari, A. R., Talarico, C., Mantelli, F., Bucci, E. M., Scorzolini, L., & Nicastri, E. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00844-6 · Cited by 67
Nie, R., Wang, S., Yang, Q., Fan, C., Liu, Y., He, W., Jiang, M., Liu, C., Zeng, W., Wu, J., et al. (2020) · medRxiv · doi:10.1101/2020.03.22.20041061 · Cited by 67
Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine
Bonam, S. R., Muller, S., Bayry, J., & Klionsky, D. J. (2020) · Autophagy · doi:10.1080/15548627.2020.1779467 · Cited by 68
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)
Khodadadi, E., Maroufi, P., Khodadadi, E., Esposito, I., Ganbarov, K., Espsoito, S., Yousefi, M., Zeinalzadeh, E., & Kafil, H. S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104241 · Cited by 67
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in CellsPreprint
Andres, A. D., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B. P., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256776 · Cited by 67
A complication of coronavirus disease 2019: delirium
Cipriani, G., Danti, S., Nuti, A., Carlesi, C., Lucetti, C., & Di Fiorino, M. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01401-7 · Cited by 65
Chen, J., Bai, H., Liu, J., Chen, G., Liao, Q., Yang, J., Wu, P., Wei, J., Ma, D., Chen, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa920 · Cited by 65
Impact of COVID-19 Pandemic on Laboratory Utilization
Durant, T. J. S., Peaper, D. R., Ferguson, D. J. P., & Schulz, W. L. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa121 · Cited by 65
Kiew, L. V., Chang, C.-Y., Huang, S., Wang, P., Heh, C.-H., Liu, C.-T., Cheng, C.-H., Lu, Y.-X., Chen, Y., Huang, Y.-X., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113213 · Cited by 64
Personal Protective Equipment and COVID-19
Stewart, C. L., Thornblade, L. W., Diamond, D. J., Fong, Y., & Melstrom, L. G. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003991 · Cited by 63
Teralı, K., Baddal, B., & Gülcan, H. O. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107697 · Cited by 64
The Cellular basis of loss of smell in 2019-nCoV-infected individuals
Gupta, K., Mohanty, S. K., Mittal, A., Kalra, S., Kumar, S., Mishra, T., Ahuja, J., Sengupta, D., & Ahuja, G. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa168 · Cited by 62
Arterial Hypertension as a Risk Comorbidity Associated with COVID‐19 Pathology
Kamyshnyi, O., Krynytska, І., Matskevych, V. M., Марущак, М. І., & Lushchak, O. V. (2020) · International Journal of Hypertension · doi:10.1155/2020/8019360 · Cited by 76
Next-Generation Sequencing Reveals the Progression of COVID-19
Chen, X., Kang, Y., Luo, J., Pang, K., Xu, X. Y., Wu, J., Li, X., & Jin, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.632490 · Cited by 69
Nhean, S., Varela, M. E., Nguyen, Y.-N., Juarez, A., Huynh, T., Udeh, D., & Tseng, A. L.-I. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211048139 · Cited by 68
Awogbindin, I. O., Ben‐Azu, B., Olusola, B. A., Akinluyi, E. T., Adeniyi, P. A., Paolo, T. D., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670298 · Cited by 61
Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients
Huang, R., Zhu, C., Wang, J., Xue, L., Li, C., Yan, X., Huang, S., Zhang, B., Zhu, L., Xu, T., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173556 · Cited by 63
Self-citationPotential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning ApproachesPreprint
Zhavoronkov, A. A., Aladinskiy, V., Zhebrak, A., Zagribelnyy, B. A., Terentiev, V. A., Bezrukov, D. S., Polykovskiy, D. A., Shayakhmetov, R., Filimonov, A., Orekhov, P. S., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11829102.v2 · Cited by 63
The eye as the discrete but defensible portal of coronavirus infection
Coroneo, M. T. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.05.011 · Cited by 62
The Rationale for Potential Pharmacotherapy of COVID-19
Saber-Ayad, M. M., Saleh, M. A., & Abu‐Gharbieh, E. (2020) · Pharmaceuticals · doi:10.3390/ph13050096 · Cited by 59
Animal models for emerging coronavirus: progress and new insights
Yuan, L., Tang, Q., Cheng, T., & Xia, N. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1764871 · Cited by 60
Cadegiani, F., Goren, A., & Wambier, C. G. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110112 · Cited by 56
Tizaoui, K., Zidi, I., Lee, K. H., Ghayda, R. A., Hong, S. H., Li, H., Smith, L., Koyanagi, A., Jacob, L., Kronbichler, A., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.48812 · Cited by 57
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
Pelaia, C., Calabrese, C., Garofalo, E., Bruni, A., Vatrella, A., & Pelaia, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063059 · Cited by 62
Kastora, S. L., Kounidas, G., Perrott, S. L., Carter, B., Hewitt, J., & Myint, P. K. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100896 · Cited by 60
Abdullahi, I. N., Emeribe, A. U., Ajayi, O. A., Oderinde, B. S., Amadu, D. O., & Osuji, A. I. (2020) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2020.06.005 · Cited by 58
Xu, T., Gao, X., Wu, Z., Selinger, D. W., & Zhou, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.01.017624 · Cited by 57
The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?
Hassan, S., Jawad, M. J., Ahjel, S. W., Singh, R. P., Singh, J., Awad, S. M., & Hadi, N. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.134-138 · Cited by 55
Badraoui, R., Adnan, M., Bardakçi, F., & Alreshidi, M. M. (2021) · Molecules · doi:10.3390/molecules26030673 · Cited by 58
Sex Hormones and Lung Inflammation
Reyes-García, J., Montaño, L. M., Carbajal-García, A., & Wang, Y.-X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_15 · Cited by 60
Self-citationKumar, S., Sarma, P., Kaur, H., Prajapat, M., Bhattacharyya, A., Avti, P., Sehkhar, N., Kaur, H., Bansal, S., Mahendiratta, S., et al. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101497 · Cited by 60
CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS
Nasonov, E. L. (2020) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2020-123-132 · Cited by 59
Mohammadpour, S., Esfahani, A. T., Halaji, M., Lak, M., & Ranjbar, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29868 · Cited by 55
Oscanoa, T. J., Romero‐Ortuño, R., Carvajal, A., & Savarino, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106078 · Cited by 54
Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, ChinaPreprint
Luo, X., Xia, H., Yang, W., Wang, B., Guo, T., Xiong, J., Jiang, Z., Liu, Y., Yan, X., Zhou, W., et al. (2020) · medRxiv · doi:10.1101/2020.03.19.20033175 · Cited by 53
Lega, S., Naviglio, S., Volpi, S., & Tommasini, A. (2020) · Vaccines · doi:10.3390/vaccines8020224 · Cited by 56
Liu, M., Zheng, B. J., Zhang, Y., & Li, J. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.05.003 · Cited by 53
Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
Carter-Timofte, M. E., Jørgensen, S. E., Freytag, M. R., Thomsen, M. M., Andersen, N.-S. B., Al-Mousawi, A., Hait, A. S., & Mogensen, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01606 · Cited by 52
Asrani, P., & Hassan, M. I. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03935-z · Cited by 52
Viswanathan, V., Puvvula, A., Jamthikar, A. D., Saba, L., Johri, A. M., Kotsis, V., Khanna, N. N., Dhanjil, S. K., Majhail, M., Misra, D. P., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i3.215 · Cited by 53
Vitamin D3 as Potential Treatment Adjuncts for COVID-19
Malaguarnera, L. (2020) · Nutrients · doi:10.3390/nu12113512 · Cited by 54
Cai, G. (2020) · Preprints.org · doi:10.20944/preprints202002.0051.v2 · Cited by 52
COVID-19: Molecular and Cellular Response
Alipoor, S. D., Mortaz, E., Jamaati, H., Tabarsi, P., Bayram, H., Varahram, M., & Adcock, I. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.563085 · Cited by 53
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity
Amin, S., Aktar, S., Rahman, M. M., & Chowdhury, M. M. H. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2021.104913 · Cited by 51
An updated min-review on environmental route of the SARS-CoV-2 transmission
Hoseinzadeh, E., Javan, S., Farzadkia, M., Mohammadi, F., Hossini, H., & Taghavi, M. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111015 · Cited by 50
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs
Abuo‐Rahma, G. E. A., Mohamed, M. F. A., Ibrahim, T. S., Shoman, M. E., Samir, E., & El-Baky, R. M. A. (2020) · RSC Advances · doi:10.1039/d0ra05821a · Cited by 49
Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates
Elemam, N. M., Hannawi, H., Salmi, I. A., Naeem, K., Alokaily, F., & Hannawi, S. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.2.25700 · Cited by 50
Subunit Nanovaccine with Potent Cellular and Mucosal Immunity for COVID-19
Liu, L., Liu, Z., Chen, H., Liu, H., Gao, Q., Cong, F., Gao, G., & Chen, Y. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00668 · Cited by 50
Martins‐Chaves, R. R., Gomes, C. C., & Gomez, R. S. (2020) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2020.vol34.0048 · Cited by 49
Cobre, A. D. F., Böger, B., Fachi, M. M., Vilhena, R. D. O., Domingos, E. L., Tonin, F. S., & Pontarolo, R. (2020) · Ciência & Saúde Coletiva · doi:10.1590/1413-812320202510.2.26882020 · Cited by 49
Vertical Transmission of SARS-CoV-2: A Systematic Review of Systematic Reviews
Musa, S. S., Bello, U. M., Zhao, S., Abdullahi, Z., Lawan, M. A., & He, D. (2021) · Viruses · doi:10.3390/v13091877 · Cited by 52
Galstyan, G. M. (2020) · PULMONOLOGIYA · doi:10.18093/0869-0189-2020-30-5-645-657 · Cited by 49
Tan, H. W., Xu, Y., & Lau, A. T. Y. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2122 · Cited by 47
Gyebi, G. A., Adegunloye, A. P., Ibrahim, I. M., Ogunyemi, O. M., Afolabi, S. O., & Ogunro, O. B. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1835726 · Cited by 49
Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment
Witika, B. A., Makoni, P. A., Mweetwa, L. L., Ntemi, P. V., Chikukwa, M. T. R., Matafwali, S. K., Mwila, C., Mudenda, S., Katandula, J., & Walker, R. B. (2020) · Molecules · doi:10.3390/molecules25245952 · Cited by 49
Srivastava, N., Garg, P., Srivastava, P., & Seth, P. K. (2021) · PeerJ · doi:10.7717/peerj.11171 · Cited by 47
Nayarisseri, A., Khandelwal, R., Madhavi, M., Selvaraj, C., Panwar, U., Sharma, K., Hussain, T., & Singh, S. K. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200704135327 · Cited by 48
Barros, R. O., Fabio, L. C. C., Pereira, W. S., Oliveira, N. M. N., & Ramos, R. M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00327 · Cited by 47
Ricke, D. O., & Malone, R. W. (2020) · SSRN Electronic Journal · doi:10.20944/preprints202003.0138.v1 · Cited by 48
CD‐sACE2 inclusion compounds: An effective treatment for coronavirus disease 2019 (COVID‐19)
Sun, P., Lu, X., Xu, C., Wang, Y., Sun, W., & Xi, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25804 · Cited by 47
Self-citationAdvanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis
Mehta, M., Prasher, P., Sharma, M., Shastri, M. D., Khurana, N., Vyas, M., Dureja, H., Gupta, G., Anand, K., Satija, S., et al. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110254 · Cited by 47
Repurposing existing drugs for COVID-19: an endocrinology perspective
Cadegiani, F. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00626-0 · Cited by 46
Translational adaptation of human viruses to the tissues they infect
Hernandez‐Alias, X., Benisty, H., Schaefer, M. H., & Serrano, L. G. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108872 · Cited by 45
Computational Design of 25-mer Peptide Binders of SARS-CoV‑2
Sitthiyotha, T., & Chunsrivirot, S. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c07890 · Cited by 41
Genomic analysis and comparative multiple sequences of SARS-CoV2
Chang, T.-J., Yang, D., Wang, M., Liang, K.-H., Tsai, P., Chiou, S.-H., Lin, T., & Wang, C.-T. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000335 · Cited by 44
Role of eosinophils in the diagnosis and prognostic evaluation of COVID‐19
Tan, Y., Zhou, J., Zhou, Q. T., Hu, L., & Long, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26506 · Cited by 46
Clinical characteristics of COVID-19 and its comparison with influenza pneumonia
Qu, J.-J., Chang, L. K., Tang, X., Du, Y., Yang, X., Liu, X., Han, P., & Xue, Y. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1798668 · Cited by 44
Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy
Hennighausen, L. G., & Lee, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108199 · Cited by 47
Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
Devaux, C. A., Pinault, L., Osman, I. O., & Raoult, D. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.608765 · Cited by 44
Yalcin, H. C., Sukumaran, V., Al-Ruweidi, M. K. A. A., & Shurbaji, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136703 · Cited by 51
Omoush, S. A., & Alzyoud, J. A. M. (2022) · Pathogens · doi:10.3390/pathogens11040445 · Cited by 44
ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review
Mostafa‐Hedeab, G. (2020) · Reports of Biochemistry and Molecular Biology · doi:10.29252/rbmb.9.1.97 · Cited by 43
Zhou, L., Wang, J., Liu, G., Lu, Q., Dong, R., Tian, G., Yang, J., & Peng, L. (2020) · Genomics · doi:10.1016/j.ygeno.2020.07.044 · Cited by 42
Deep learning for differentiating novel coronavirus pneumonia and influenza pneumonia
Zhou, M., Yang, D., Chen, Y., Xu, Y., Xu, J., Jie, Z., Yao, W., Jin, X., Pan, Z., Tan, J., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5328 · Cited by 41
Adli, A., Rahimi, M., Khodaie, R., Hashemzaei, N., & Hosseini, S. M. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27615 · Cited by 46
Tobacco-Use Disparity in Gene Expression of ACE2, the Receptor of 2019-nCovPreprint
Cai, G. (2020) · Preprints.org · doi:10.20944/preprints202002.0051.v1 · Cited by 43
Xu, J., Huang, C., Fan, G., Liu, Z., Shang, L., Zhou, F., Wang, Y., Yu, J., Yang, L., Xie, K., et al. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0800-y · Cited by 42
Self-citationSARS-CoV-2 (COVID-19): New Discoveries and Current Challenges
Soufi, G. J., Hekmatnia, A., Nasrollahzadeh, M., Shafiei, N., Sajjadi, M., Iravani, P., Fallah, S., Iravani, S., & Varma, R. S. (2020) · Applied Sciences · doi:10.3390/app10103641 · Cited by 41
A potential protective role of losartan against coronavirus-induced lung damage
Zeinalian, M., Salari-Jazi, A., Jannesari, A., & Khanahmad, H. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.80 · Cited by 40
The prospects for the SARS‐CoV‐2 pandemic in Africa
Quaresima, V., Naldini, M. M., & Cirillo, D. M. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012488 · Cited by 44
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
Tabaa, M. M. E., & Tabaa, M. M. E. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114057 · Cited by 42
The outlook for diagnostic purposes of the 2019‐novel coronavirus disease
Tahmasebi, S., Khosh, E., & Esmaeilzadeh, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29804 · Cited by 41
Ueyama, H. A., Kuno, T., Takagi, H., Krishnamoorthy, P. M., Vengrenyuk, Y., Sharma, S. K., Kini, A. S., & Lerakis, S. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000148 · Cited by 41
Michaud, V., Deodhar, M., Arwood, M. J., Rihani, S. B. A., Dow, P., & Turgeon, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072096 · Cited by 42
A review on scope of immuno-modulatory drugs in Ayurveda for prevention and treatment of Covid-19
Niraj, S., & Saxena, V. (2020) · Plant Science Today · doi:10.14719/pst.2020.7.3.831 · Cited by 41
Metadata
- Authors
- Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W.
- Affiliations
- Tongji University (CN)
- Regend Therapeutics (China) (CN)
- Corresponding author
- Zuo, Wei
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2020-01-26
- OpenAlex
- W3003154936
- Cited by
- 860
- References
- 20
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 19 · 2022: 56 · 2021: 194 · 2020: 576
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Locations
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- ACE2, SARS-CoV-2, COVID-19 pandemic, single-cell RNA sequencing, alveolar type II cells, lung tissue, viral receptor expression, SARS-CoV
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
